openPR Logo
Press release

Insights on the Atipamezole Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027

02-10-2022 09:03 AM CET | Health & Medicine

Press release from: Orion Market Research

The global atipamezole market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Atipamezoles is a synthetic ?? adrenergic receptor antagonist. It is an anti-sedative drug that is indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. The major factor for the growth of the market is the rising adoption of pets. According to the APPA National Pet Owners Survey 2021-2022, 70% of the US households own a pet, which equates to 90.5 million homes. Additionally, in 2019-2020, 63.4 million households had at least one dog and 42.7 million households had at least one cat. Hence, the rising adoption of pets is driving the demand for atipamezole that is used for the treatment of amitraz and imidazoline decongestants toxicity in animals. According to the American Pet Products Association (APPA), in 2020, a total of $103.6 billion was spent on pets, out of which vet care and product sales accounted for $31.4 billion. This rising awareness regarding pet health is attributing to the growth of the global atipamezole market.

To Request a Sample of our Report on Atipamezole Market: https://www.omrglobal.com/request-sample/atipamezole-market

Some major players in the market include Zoetis Inc., Merck KGaA, Pfizer Inc., and Vetoquinol SA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2021, Dechra launched ATIPAM. It is an injectable 5 mg/mL Atipamezole Hydrochloride solution that is indicated for the reversal of the clinical effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered-

· By Application

· By Route of Administration

· By Animal Type

• Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

• Competitive Landscape-Zoetis Inc., Merck KGaA, Pfizer Inc., and Vetoquinol SA, among others.

(Get 15% Discount on Buying this Report)

A full Report of Atipamezole Market is Available @: https://www.omrglobal.com/industry-reports/atipamezole-market

Global Atipamezole Market Report by Segment

By Application

• Anti-Sedative

• Anti-Toxic (Off-Label Use)

By Route of Administration

• Intravenous

• Intramuscular

• Others

By Animal Type

• Dogs

• Cats

• Others

Global Atipamezole Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights on the Atipamezole Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027 here

News-ID: 2549167 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Atipamezole

Atipamezole Market Outlook 2030: Projected to Reach US$ 70 Million by 2030, Driv …
The global Atipamezole Market, valued at approximately US$ 65 million in 2022, is projected to reach US$ 70 million by 2030, expanding at a compound annual growth rate (CAGR) of 1% from 2020 to 2030. Atipamezole, a synthetic alpha-2 adrenergic receptor antagonist, is primarily used in veterinary medicine to reverse sedative effects of drugs like dexmedetomidine and medetomidine in animals, particularly dogs and cats. The market's modest growth is driven
Atipamezole Market Booming Worldwide with Rising Use in Veterinary Reversal Agen …
Atipamezole Market Overview The Atipamezole Market is projected to reach USD 130 million by 2032 from USD 85 million in 2025, growing at a CAGR of 6.2%. Coherent Market Insights is pleased to release its latest Atipamezole Market research report, offering an in-depth analysis of the U.S. Atipamezole Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels, encompassing supply chain shifts, payer-provider dynamics, and competitive
Atipamezole Market is Expected to Reach ~US$ 70 Mn by the end of 2030
The Atipamezole market has witnessed significant growth over the past decade and is poised for continued expansion from 2020 to 2030. Atipamezole, a potent alpha-2 adrenergic antagonist, is widely used in veterinary medicine for reversing the sedative effects of alpha-2 adrenergic agonists like medetomidine and xylazine. Its efficacy in swiftly counteracting the sedative effects makes it indispensable in veterinary practice, driving its demand globally. 𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡
Saudi Arabia Atipamezole Market Size to Observe Steady Growth
The global atipamezole market is estimated to attain a valuation of ~US$ 70 Mn by the end of 2030, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 1% during the forecast period, 2020 to 2030. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Atipamezole Market Size to Expand at the CAGR of 1% during the Forecast Period 2 …
Atipamezole Market: Introduction According to the report, the global atipamezole market was valued at US$ 60 Mn in 2019. It is projected to expand at a CAGR of ~1% from 2020 to 2030. Atipamezole is a specific α2-antagonist that was developed to reverse the actions of medetomidine and has marketing authorization for dogs and cats. Medetomidine and antagonism with atipamezole is, presently widely utilized in small animal practice. The reduction in
Atipamezole Market Size 2021 | Incredible Possibilities, Growth, Trend, Opportun …
Reduction in sedative time of animals shortens the in-clinic stay, saves the time of the staff, reduces hospitalization costs, and reduces revisits of the animal owner. Furthermore, the rising pet ownership and increasing healthcare expenditure on animals are anticipated to fuel the market growth. However, adverse effects of atipamezole and stringent government regulations associated with the safety and efficacy of atipamezole is anticipated to hinder the market growth. For instance,